Moringa Acquisition Corp

GlobeNewswire Inc. · Feb 22, 2024

Silexion, a Clinical-Stage, Oncology-Focused Biotechnology Company, to Become Publicly Traded Via Business Combination with Moringa Acquisition Corp

GlobeNewswire Inc. · Aug 15, 2023

MORINGA ACQUISITION CORP ANNOUNCES CONTRIBUTION TO TRUST ACCOUNT IN CONNECTION WITH PROPOSED EXTENSION

New York, NY, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Moringa Acquisition Corp (Nasdaq: MACA) (“Moringa” or the “Company”) announced today that, in connection with its previously announced extraordinary general meeting in lieu of the 2023 annual general meeting of shareholders of the Company to be held at 9:00 a.m. Eastern Time/4:00 p.m. local (Israel) time on August 16, 2023 (the “Extraordinary Meeting”) for the purpose of considering and voting on, among other proposals, a proposal to extend the date by which the Company must consummate an initial business combination (the “Extension”) from August 19, 2023 (the “Current Termination Date”) to August 19, 2024 or such earlier date as may be determined by the Company’s board of directors, in its sole discretion (such new termination date, the “Extension Date”), the Company’s sponsor, Moringa Sponsor, L.P., and/or its wholly-owned subsidiary Moringa Sponsor (US) L.P. (collectively, the “Sponsor”), or the Sponsor’s designees, will make additional contributions to the Company’s trust account following the approval and implementation of the Extension.

GlobeNewswire Inc. · Jun 13, 2022

Holisto, a Technology-Based Online Travel Booking Platform, to Become Publicly Traded Via Business Combination with Moringa Acquisition Corp

Rishon Le’Zion, Israel and New York, New York, June 13, 2022 (GLOBE NEWSWIRE) -- Holisto Ltd, a technology based online travel booking platform (“Holisto” or the “Company”), and Moringa Acquisition Corp (Nasdaq: MACA, “Moringa”), a special purpose acquisition company, today announced they have entered into a business combination agreement that would result in Holisto becoming publicly listed on the Nasdaq. The business combination provides for Holisto Ltd.’s expected pro forma equity value to be approximately $405 million. As described below and subject to certain limitations, the transaction provides Moringa’s non-redeeming public shareholders the opportunity to receive a pro rata portion of a bonus pool of up to an additional 1,725,000 shares at transaction close, which would result in merger consideration of between 1.15 and 1.6 Holisto ordinary shares for each such Moringa Class A ordinary share not redeemed. The exact ratio of merger consideration for non-redeeming shareholders will depend on the number of Moringa shares that are redeemed.

GlobeNewswire Inc. · Apr 5, 2022

Moringa Acquisition Corp Files its Annual Report for the 2021 Year

NEW YORK, NY, April 05, 2022 (GLOBE NEWSWIRE) -- Moringa Acquisition Corp (NasdaqCM: MACA, MACAU and MACAW) (the “Company”) announced that it filed its annual report on Form 10-K for the year ended December 31, 2021 with the Securities and Exchange Commission on March 31, 2022. Copies of the annual report and other filings are available online through the Company’s website, https://www.moringaac.com/, or by accessing the Securities and Exchange Commission’s website, www.sec.gov. Copies may also be obtained from the Company, Attn: Gil Maman, 250 Park Avenue, 7th Floor, New York, NY 11040, or by email: [email protected].